NCT05987033View on ClinicalTrials.gov

Proof-of-concept Study with NVDX3 for Treatment of Distal Radius Fractures.

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 8, 2023

Primary Completion Date

December 19, 2024

Study Completion Date

December 19, 2024

Conditions

Distal Radius Fractures

Interventions

DRUG

NVDX3

NVDX3 is implanted during a single surgical intervention.

Trial Locations (1)

1210

Centre Hospitalier de Luxembourg, Luxembourg

Sponsors

Lead Sponsor

Novadip Biosciences

Collaborators (1)

All Listed Sponsors

collaborator

PrimeVigilance

INDUSTRY

collaborator

Data Investigation Company Europe (DICE)

UNKNOWN

lead

Novadip Biosciences

INDUSTRY

NCT05987033 - Proof-of-concept Study with NVDX3 for Treatment of Distal Radius Fractures. | Biotech Hunter | Biotech Hunter